Acorda Therapeutics reported $75.77M in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US USD 425.69M 9.16M
Acorda Therapeutics ACOR:US USD 75.77M 12.14M
Agios Pharmaceuticals AGIO:US USD 1.05B 73.9M
Amgen AMGN:US USD 3.66B 8M
Anika Therapeutics ANIK:US USD 284.94M 1.22M
Aptinyx Inc APTX:US USD 48.79M 13.31M
Arrowhead Research ARWR:US USD 398.52M 55.41M
Biogen BIIB:US USD 12.78B 903M
Biomarin Pharmaceutical BMRN:US USD 4.57B 63.71M
Cara Therapeutics CARA:US USD 184.82M 19.6M
Clovis Oncology CLVS:US USD -417886000 50.19M
Cytokinetics CYTK:US USD -15977000 127.39M
Enanta Pharmaceuticals ENTA:US USD 321.33M 16.69M
Gilead Sciences GILD:US USD 21.21B 128M
GlaxoSmithKline GSK:LN GBP 10.6B 1.45B
Halozyme Therapeutics HALO:US USD 96.99M 196.18M
Heron Therapeutics HRTX:US USD 22.45M 44.19M
Insmed INSM:US USD -29959000 74.2M
Ligand Pharmaceuticals LGND:US USD 816.3M 13.93M
Mannkind MNKD:US USD -237677000 9.38M
Merck MRK:GR EUR 28.26B 2.31B
Moderna Inc MRNA:US USD 17.99B 7M
Neurocrine Biosciences NBIX:US USD 1.54B 121.2M
Novartis NOVN:VX USD 60.82B 2.1B
Teva Pharmaceutical TEVA:IT USD 8.77B 269M
Ultragenyx Pharmaceutical RARE:US USD 468.83M 209.24M
Vertex Pharmaceuticals VRTX:US USD 13.03B 1.1B